Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,476 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oxidative stress and mitochondrial adaptive shift during pituitary tumoral growth.
Sabatino ME, Grondona E, Sosa LDV, Mongi Bragato B, Carreño L, Juarez V, da Silva RA, Remor A, de Bortoli L, de Paula Martins R, Pérez PA, Petiti JP, Gutiérrez S, Torres AI, Latini A, De Paul AL. Sabatino ME, et al. Free Radic Biol Med. 2018 May 20;120:41-55. doi: 10.1016/j.freeradbiomed.2018.03.019. Epub 2018 Mar 13. Free Radic Biol Med. 2018. PMID: 29548793
Trastuzumab inhibits pituitary tumor cell growth modulating the TGFB/SMAD2/3 pathway.
Petiti JP, Sosa LDV, Picech F, Moyano Crespo GD, Arevalo Rojas JZ, Pérez PA, Guido CB, Leimgruber C, Sabatino ME, García P, Bengio V, Papalini FR, Estario P, Berhard C, Villarreal M, Gutiérrez S, De Paul AL, Mukdsi JH, Torres AI. Petiti JP, et al. Among authors: perez pa. Endocr Relat Cancer. 2018 Oct;25(10):837-852. doi: 10.1530/ERC-18-0067. Epub 2018 Jun 6. Endocr Relat Cancer. 2018. PMID: 29875136
The ERα membrane pool modulates the proliferation of pituitary tumours.
Sosa LDV, Petiti JP, Picech F, Chumpen S, Nicola JP, Perez P, De Paul A, Valdez-Taubas J, Gutierrez S, Torres AI. Sosa LDV, et al. Among authors: perez p. J Endocrinol. 2019 Feb 1;240(2):229-241. doi: 10.1530/JOE-18-0418. J Endocrinol. 2019. PMID: 30400032
mPRs represent a novel target for PRL inhibition in experimental prolactinomas.
Camilletti MA, Abeledo-Machado A, Perez PA, Faraoni EY, De Fino F, Rulli SB, Ferraris J, Pisera D, Gutierrez S, Thomas P, Díaz-Torga G. Camilletti MA, et al. Among authors: perez pa. Endocr Relat Cancer. 2019 May;26(5):497-510. doi: 10.1530/ERC-18-0409. Endocr Relat Cancer. 2019. PMID: 30856609
1,476 results